Table 1 Patients’ baseline characteristics
Variables | Unweighted study population | Weighted study population | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
All cohort (n = 149) | Chloral hydrate group (n = 75) | Dexmedetomidine group (n = 74) | Statistic | p Value | SMD | All cohort (n = 298) | Chloral hydrate group (n = 150) | Dexmedetomidine group (n = 148) | Statistic | p Value | SMD | |
Age (months) | 14 [8–24] | 11 [7–22] | 16.5 [9–24] | 2.21 | 0.027 | 0.11 | 15 [8–24] | 12 [7–24] | 16 [9–24] | − 0.41 | 0.6794 | 0.03 |
Weight (kg) | 8 [6.5–11] | 7 [6–10] | 9 [7–11] | 1.69 | 0.09 | 0.15 | 8 [6.5–11] | 7.5 [6–11] | 9 [6.6–11] | 0.93 | 0.3534 | 0.03 |
Sex | ||||||||||||
Male | 73 (49) | 36 (48) | 37 (50) | 0.06 | 0.8071 | 0.04 | 147 (49.3) | 74 (49.4) | 73 (49.3) | 0.00 | 0.981 | < 0.01 |
Female | 76 (51) | 39 (52) | 37 (50) | 151 (50.7) | 76 (50.6) | 75 (50.7) | ||||||
Type of CHD | ||||||||||||
Simple cases | 84 (56.4) | 43 (57.3) | 41 (55.4) | 0.06 | 0.8125 | 0.04 | 167 (55.9) | 84 (55.8) | 83 (56) | 0.00 | 0.9726 | < 0.01 |
Complex cases | 65 (43.6) | 32 (42.7) | 33 (44.6) | 131 (44.1) | 66 (44.2) | 65 (44) | ||||||
Fasting time | ||||||||||||
≤ 3 h | 91 (61.1) | 44 (58.7) | 47 (63.5) | 0.37 | 0.5441 | 0.1 | 182 (61.1) | 91 (61) | 91 (61.3) | 0.00 | 0.9477 | 0.01 |
> 3 h | 58 (38.9) | 31 (41.3) | 27 (36.5) | 116 (38.9) | 58 (39) | 57 (38.7) | ||||||